Unresectable Squamous
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/Rectum (NCT07511023) | M.D. Anderson Cancer Center | 2026-09-25 |
Track Unresectable Squamous automatically
Every clearance here is in the API, with alerts when new ones post.